Lafayette, LA – (July 5, 2022) Biologics company Tides Medical® announces the launch of a new product, Artacent AC®, a tri-layer skin graft designed for use in the treatment of complex or difficult-to-treat wounds.

Tides developed Artacent AC to offer clinicians another amniotic skin graft option featuring 3 layers (amnion-chorion-amnion) instead of the traditional 2 (amnion-amnion). The product is available now — support for specific MAC regions is available through Tides' reimbursement specialists.

"With its greater per unit mass, its thicker, tri-layer structure and greater strength, Artacent AC offers clinicians an improved solution for treating complex patient wounds," said Senior Product Manager Gary Monteiro, PhD.

Tides' skin substitutes are used to treat a variety of medical conditions, including diabetic foot ulcers, chronic wounds, burns, Mohs surgery, and various surgical applications. Allografts like Artacent AC can be placed on either side facing the wound. It stores dry at room temperature with no need for refrigeration, remaining safe and effective up to 5 years from the date of manufacturing.

Founded in 2010, Tides manufactures a number of versatile placental skin grafts derived from donated birth tissue. All Tides products are manufactured entirely in-house using donated human placental tissue. A proprietary Artacleanse® process is used to make the graft safe for implantation while maintaining its natural biologic factors, including high molecular weight proteins.

"We're proud to be known for combining advanced medical technology with customer service and support that is second-to-none," said Joe Spell, CEO of Tides. "The development and launch of Artacent AC are part of our larger mission: revolutionizing access to the power of birth tissue technology."

About Tides Medical
Tides Medical is committed to bringing amniotic tissue grafts to patients. They acquire, produce and deliver products to ensure the highest standards for safety and effectiveness are always met.

The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, HMP Global, its affiliates, or subsidiary companies.